本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Adaptive Biotechnologies Corp

7.79
-0.0350-0.45%
成交量:26.56萬
成交額:208.08萬
市值:11.57億
市盈率:-7.18
高:8.01
開:7.78
低:7.71
收:7.82
資料載入中...
2025/03/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/11

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/05

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities